Caxton Associates (New York)’s Entegris ENTG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-160,000
Closed -$21.7M 560
2024
Q2
$21.7M Buy
160,000
+131,589
+463% +$17.4M 0.74% 20
2024
Q1
$3.99M Buy
+28,411
New +$3.63M 0.22% 50
2023
Q1
Sell
-10,435
Closed -$684K 529
2022
Q4
$684K Buy
+10,435
New +$768K 0.05% 184
2020
Q4
Sell
-7,020
Closed -$522K 189
2020
Q3
$522K Buy
+7,020
New +$471K 0.05% 111
2020
Q1
Sell
-12,227
Closed -$612K 448
2019
Q4
$612K Buy
+12,227
New +$590K 0.08% 140

Other funds holding ENTG

Caxton Associates (New York)'s ENTG Position: Q3 2024 in Review

Caxton Associates (New York) sold out of Entegris (ENTG) in Q3 2024, closing a stake of 160,000 shares — an estimated $21.7M sold.

Caxton Associates (New York) first reported a position in ENTG in Q4 2019 and held it in 5 quarters. The position peaked at $21.7M in Q2 2024. 591 funds tracked by Wall St. Rank hold ENTG as of Q3 2024.

  • Caxton Associates (New York) reported no remaining Entegris position as of Q3 2024 after selling out during the quarter.
  • Caxton Associates (New York) sold 160,000 Entegris shares in Q3 2024, an estimated $21.7M.
  • Caxton Associates (New York) first reported a position in Entegris in Q4 2019 and held it in 5 quarters.
  • Caxton Associates (New York)'s Entegris position peaked at $21.7M in Q2 2024.
  • 591 funds tracked by Wall St. Rank held Entegris as of Q3 2024.

Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.